The reliability of the MSFC and its components

Acta Neurologica Scandinavica

Volumn 117, Issue 6, 2008, Pages 421-427

  Rosti Otajarvi E ^a,b   Hamalainen P ^c   Koivisto, K ^a   Hokkanen, L ^d  

^a SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c Maskun Neurologinen Kuntoutuskeskus   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Clinical trials; Multiple sclerosis; Multiple Sclerosis Functional Composite; Paced Auditory Serial Addition Test; Practice effects; Reliability

Indexed keywords

ADULT; ARM MOVEMENT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; INTERRATER RELIABILITY; INTRARATER RELIABILITY; MALE; MEASUREMENT; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS FUNCTIONAL COMPOSITE; NINE HOLE PEG TEST; PACED AUDITORY SERIAL ADDITION TEST; RATING SCALE; RELAPSE; REMISSION; TIMED 25 FOOT WALK;

ADULT; ANALYSIS OF VARIANCE; DISABILITY EVALUATION; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROGNOSIS; REPRODUCIBILITY OF RESULTS;

EID: 43149102245     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2007.00972.x     Document Type: Article

References (35)

1. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983 33 : 1444 52.
2. Whitaker JN, Mcfarland HF, Rudge P, Reingold SC. Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Mult Scler 1995 1 : 37 47.
3. Rudick R, Antel J, Confavreux C et al. Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol 1997 42 : 379 82.
4. Cutter GR, Baier ML, Rudick RA et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999 122 : 871 82.
5. Cohen JA, Fischer JS, Bolibrush DM et al. Intrarater and interrater reliability of the MS functional composite outcome measure. Neurology 2000 54 : 802 6.
6. Cohen JA, Cutter GR, Fischer JS et al. Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. Arch Neurol 2001 58 : 961 7.
7. Solari A, Radice D, Manneschi L, Motti L, Montanari E. The multiple sclerosis functional composite: different practice effects in the three test components. J Neurol Sci 2005 228 : 71 4.
8. Beglinger LJ, Gaydos B, Tangphao-Daniels O et al. Practice effects and the use of alternate forms in serial neuropsychological testing. Arch Clin Neuropsychol 2005 20 : 517 29.
9. Dyche GM, Johnson DA. Development and evaluation of CHIPASAT, an attention test for children: II. Test-retest reliability and practice effect for a normal sample. Percept Mot Skills 1991 72 : 563 72.
10. Gronwall DM. Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 1977 44 : 367 73.
11. Mccaffrey RJ, Cousins JP, Westervelt HJ et al. Practice effects with the NIMH AIDS abbreviated neuropsychological battery. Arch Clin Neuropsychol 1995 10 : 241 50.
12. O'jile JR, Ryan LM, Betz B et al. Information processing following mild head injury. Arch Clin Neuropsychol 2006 21 : 293 6.
13. Schächinger H, Cox D, Linder L, Brody S, Keller U. Cognitive and psychomotor function in hypoglycemia: response error patterns and retest reliability. Pharmacol Biochem Behav 2003 75 : 915 20.
14. Barker-Collo SL. Within session practice effects on the PASAT in clients with multiple sclerosis. Arch Clin Neuropsychol 2005 20 : 145 52.
15. Beatty WW, Goretti B, Siracusa G, Zipoli V, Portaccio E, Amato MP. Changes in neuropsychological test performance over the workday in multiple sclerosis. Clin Neuropsychol 2003 17 : 551 60.
16. Bever CT, Grattan L, Panitch HS, Johnson KP. The Brief Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: a preliminary serial study. Mult Scler 1995 1 : 165 9.
17. Fischer JS, Priore RL, Jacobs LD et al. Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann Neurol 2000 48 : 885 92.
18. Johnson SK, Lange G, Deluca J, Korn LR, Natelson B. The effects of fatigue on neuropsychological performance in patients with chronic fatigue syndrome, multiple sclerosis, and depression. Appl Neuropsychol 1997 4 : 145 53.
19. Patzold T, Schwengelbeck M, Ossege LM, Malin JP, Sindern E. Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis. Acta Neurol Scand 2002 105 : 164 8.
20. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 13 : 227 31.
21. Fischer JS, Jak AJ, Kniker JE, Rudick RA, Cutter G. Multiple Sclerosis Functional Composite (MSFC) - Administration and scoring manual - revised, National Multiple Sclerosis Society, New York, 2001.
22. Rosti E, Hämäläinen P, Koivisto K, Hokkanen L. The PASAT performance among patients with multiple sclerosis: analyses of responding patterns using different scoring methods. Mult Scler 2006 12 : 586 93.
23. Rosti E, Hämäläinen P, Koivisto K, Hokkanen L. PASAT in detecting cognitive impairment in relapsing-remitting MS. Appl Neuropsychol 2007 14 : 101 12.
24. Crawford JR, Obonsawin MC, Allan KM. PASAT and components of WAIS-R performance: convergent and discriminant validity. Neuropsychol Rehab 1998 8 : 255 72.
25. Egan V. PASAT: observed correlations with IQ. Person Individ Diff 1988 9 : 179 80.
26. Holdwick DJ, Wingenfeld SA. The subjective experience of PASAT testing: does the PASAT induce negative mood? Arch Clin Neuropsychol 1999 14 : 273 84.
27. Fos LA, Greve KW, South MB, Mathias C, Benefield H. Paced Visual Serial Addition Test: an alternative measure of information processing speed. Appl Neuropsychol 2000 7 : 140 46.
28. Lezak MD. Neuropsychological assessment, 3rd edn. New York : Oxford University Press, 1995.
29. Fisk JD, Archibald CJ. Limitations of the Paced Auditory Serial Addition Test as a measure of working memory in patients with multiple sclerosis. J Int Neuropsychol Soc 2001 7 : 363 72.
30. Coo H, Hopman WM, Edgar CM, Mcbride EV, Brunet DG. The Paced Auditory Serial Addition Test: to what extent is it performed as instructed, and is it associated with disease course? Mult Scler 2005 11 : 85 9.
31. Kujala P, Portin R, Revonsuo A, Ruutiainen J. Attention related performance in two cognitively different subgroups of patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 1995 59 : 77 82.
32. Snyder PJ, Cappelleri JC, Archibald CJ, Fisk JD. Improved detection of differential information-processing speed deficits between two disease-course types of multiple sclerosis. Neuropsychology 2001 15 : 617 25.
33. Uitdehaag BM, Ader HJ, Roosma TJ, De groot V, Kalkers NF, Polman CH. Multiple Sclerosis Functional Composite: impact of reference population and interpretation of changes. Mult Scler 2002 8 : 366 71.
34. Tombaugh TN. A comprehensive review of the Paced Auditory Serial Addition Test (PASAT). Arch Clin Neuropsychol 2006 21 : 53 76.
35. Feinstein A, Brown R, Ron M. Effects of practice of serial tests of attention in healthy subjects. J Clin Exp Neuropsychol 1994 16 : 436 47.